The Interim Financial Statements and the MD&A should be up on SEDAR by tomorrow.

Heres’s an excerpt from the MD&A:

MANAGEMENT’S DISCUSSION AND ANALYSIS

The Company

Sonomax Technologies Inc. (formerly Sonomax Hearing Healthcare, Inc.) (TSXV: SHH) engages in the development, commercialization and sales of intra-ear technology for earphones, hearing protection, hearing enhancement, and other communication applications.

Under the leadership of a new senior management team, Sonomax Technologies Inc. has leveraged off the Company’s past technological achievements to develop an earpiece that an individual can easily and permanently customize to the exact shape of their ear in minutes; officially dubbed SonoFit™. This breakthrough is significant because it represents the first time that in-ear products (Bluetooth™, MP3 players, military communication, hearing protection, hearing aids) have the potential to feature a custom fit for optimized device performance and comfort on a mass scale.

To put this in context, customization has been limited to the high end product offerings that were combined with hand made ear molds. In addition to this unlimited scalability, the new Sonomax Technologies Inc. earpiece technology has been designed to allow it to be integrated with current in-ear product offerings across all in-ear applications.

To fully exploit the potential of the Company’s new self-fit delivery platform, Sonomax has chosen to pursue a strategy of greater market visibility and demonstrated user validation. Specifically, Sonomax has started to commercialize and is now selling its unique brand of custom fitted earphones, sculpted eers™, direct to selected retailers with the assistance and support of the Levin Consulting Group. This exercise is not only designed to generate revenue but also demonstrate the viability of the technology in the retail space. It is anticipated that this example will open up other opportunities for distribution such as the recently announced distribution agreement with JAM Industries as well as licensing of the Company’s technology for other in-ear products to Original Equipment Manufacturers, such as the recently announced licensing agreement with Skullcandy®. Sonomax will finally be able to report on sales of sculpted eers and revenue from Licensing in the next few quarters.

The SonoFit™ is positioned to become truly ubiquitous across all in-ear product applications.

The following discussion and analysis provides a review of current activities and a comparison of the performance and consolidated financial position of Sonomax Technologies Inc. for the three-month and six-month periods ended June 30, 2011 and 2010. It should be read in conjunction with the audited consolidated financial statements and accompanying notes for the years ended December 31, 2010 and 2009, which were prepared in accordance with Canadian GAAP. The financial data in this document has been prepared in accordance with International Financial Reporting Standards (‘IFRS”) with comparative figures adjusted accordingly as applicable. Additional information relating to the Company can be found on SEDAR at www.sedar.com.

Additional information relating to the Company can be found on SEDAR at www.sedar.com

Comments in this report are as of August 26, 2011.